Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets

About this update from Transgene Sa

[{"type":"image","alt":"Transgene S.A.","displaySize":"","headline":null,"caption":"Transgene S.A.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":87,"url":"https://media.zenfs.com/en/globenewswire.com/014a32ee8cbaadbe40e6ba7be426a3a8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LxPyLyDB4_EySFq7GvMDzg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/014a32ee8cbaadbe40e6ba7be426a3a8","width":300,"height":87}},"lazy":false},{"type":"text","content":"Strasbourg, France, 27 November 2025, 00:15 a.m. CET – Transgene (Euronext Paris: TNG) had requested the suspension of trading of its shares (ISIN: FR0005175080) on Euronext Paris as from Wednesday, 26 November 2025, before market opening, pending the publication of the results of its capital increase.","length":303,"tagName":"p"},{"type":"text","content":"Following the announcement of the results of its capital increase on 26 November 2025, trading of its shares on Euronext Paris will resume on Thursday, 27 November 2025, at market opening.","length":188,"tagName":"p"},{"type":"text","content":"***","length":3,"tagName":"p"},{"type":"text","content":"Contacts ","length":8,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:385px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Transgene:","length":10,"tagName":"p","attribs":{}}]},{"style":"width:227.27px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:385px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Media:","length":6,"tagName":"p","attribs":{}}]},{"style":"width:227.27px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Investors & Analysts:","length":25,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:385px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Caroline Tosch","length":14,"tagName":"p","attribs":{}}]},{"style":"width:227.27px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Lucie Larguier","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:385px;text-...

More updates from Transgene Sa